BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2167951)

  • 1. Severe hepatic toxicity after treatment with vincristine and dactinomycin using single-dose or divided-dose schedules: a report from the National Wilms' Tumor Study.
    Green DM; Norkool P; Breslow NE; Finklestein JZ; D'Angio GJ
    J Clin Oncol; 1990 Sep; 8(9):1525-30. PubMed ID: 2167951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe hepatic toxicity after treatment with single-dose dactinomycin and vincristine. A report of the National Wilms' Tumor Study.
    Green DM; Finklestein JZ; Norkool P; D'Angio GJ
    Cancer; 1988 Jul; 62(2):270-3. PubMed ID: 2838151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison between single-dose and divided-dose administration of dactinomycin and doxorubicin for patients with Wilms' tumor: a report from the National Wilms' Tumor Study Group.
    Green DM; Breslow NE; Beckwith JB; Finklestein JZ; Grundy PE; Thomas PR; Kim T; Shochat SJ; Haase GM; Ritchey ML; Kelalis PP; D'Angio GJ
    J Clin Oncol; 1998 Jan; 16(1):237-45. PubMed ID: 9440748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Veno-occlusive disease of the liver and nephroblastoma in children (role of the vincristine-actinomycin combination?].
    Chevallier B; Treluyer JM; Devictor D; Yaiche MC; Lagardère B
    Ann Pediatr (Paris); 1988 Sep; 35(7):525-6. PubMed ID: 2460015
    [No Abstract]   [Full Text] [Related]  

  • 5. Unexpected toxicity encountered in the National Wilms' Tumor Study.
    D'Angio GJ
    Cancer Treat Rep; 1987 Oct; 71(10):993. PubMed ID: 2820573
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of duration of treatment on treatment outcome and cost of treatment for Wilms' tumor: a report from the National Wilms' Tumor Study Group.
    Green DM; Breslow NE; Beckwith JB; Finklestein JZ; Grundy P; Thomas PR; Kim T; Shochat S; Haase G; Ritchey M; Kelalis P; D'Angio GJ
    J Clin Oncol; 1998 Dec; 16(12):3744-51. PubMed ID: 9850017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy-related toxicity in infants treated according to the Second National Wilms' Tumor Study.
    Morgan E; Baum E; Breslow N; Takashima J; D'Angio G
    J Clin Oncol; 1988 Jan; 6(1):51-5. PubMed ID: 2826715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal duration of preoperative therapy in unilateral and nonmetastatic Wilms' tumor in children older than 6 months: results of the Ninth International Society of Pediatric Oncology Wilms' Tumor Trial and Study.
    Tournade MF; Com-Nougué C; de Kraker J; Ludwig R; Rey A; Burgers JM; Sandstedt B; Godzinski J; Carli M; Potter R; Zucker JM;
    J Clin Oncol; 2001 Jan; 19(2):488-500. PubMed ID: 11208843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Veno-occlusive disease of the liver as a treatment complication in children with Wilm's tumor].
    Zoubek A; Wiesbauer P; Pracher E; Martins da Cunha AC; Emminger W; Grois N; Gadner H
    Padiatr Padol; 1992; 27(2):47-50. PubMed ID: 1318536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dactinomycin and vincristine toxicity in the treatment of childhood cancer: a retrospective study from the Children's Oncology Group.
    Langholz B; Skolnik JM; Barrett JS; Renbarger J; Seibel NL; Zajicek A; Arndt CA
    Pediatr Blood Cancer; 2011 Aug; 57(2):252-7. PubMed ID: 21671362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-dose versus fractionated-dose dactinomycin in the treatment of Wilms' tumor. Preliminary results of a clinical trial. The Brazilian Wilms' Tumor Study Group.
    de Camargo B; Franco EL
    Cancer; 1991 Jun; 67(12):2990-6. PubMed ID: 1646068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of children with stages II to IV anaplastic Wilms' tumor: a report from the National Wilms' Tumor Study Group.
    Green DM; Beckwith JB; Breslow NE; Faria P; Moksness J; Finklestein JZ; Grundy P; Thomas PR; Kim T; Shochat S
    J Clin Oncol; 1994 Oct; 12(10):2126-31. PubMed ID: 7931483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of chemotherapy dose intensity on the hematological toxicity of the treatment for Wilms' tumor. A report from the National Wilms' Tumor Study.
    Green DM; Breslow NE; Evans I; Moksness J; Finklestein JZ; Evans AE; D'Angio GJ
    Am J Pediatr Hematol Oncol; 1994 Aug; 16(3):207-12. PubMed ID: 8037337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe chemotherapy-related hepatic toxicity associated with MZ protease inhibitor phenotype.
    Ruchelli ED; Horn M; Taylor SR
    Am J Pediatr Hematol Oncol; 1990; 12(3):351-4. PubMed ID: 2173441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal failure does not preclude cure in children receiving chemotherapy for Wilms tumor: a report from the National Wilms Tumor Study Group.
    Feusner JH; Ritchey ML; Norkool PA; Takashima JR; Breslow NE; Green DM
    Pediatr Blood Cancer; 2008 Feb; 50(2):242-5. PubMed ID: 17458877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of the United Kingdom Children's Cancer Study Group first Wilms' Tumor Study.
    Pritchard J; Imeson J; Barnes J; Cotterill S; Gough D; Marsden HB; Morris-Jones P; Pearson D
    J Clin Oncol; 1995 Jan; 13(1):124-33. PubMed ID: 7799012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute toxicities associated with radiation in the second National Wilms' Tumor Study.
    Thomas PR; Tefft M; D'Angio GJ; Norkool P
    J Clin Oncol; 1988 Nov; 6(11):1694-8. PubMed ID: 2846791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of children with clear-cell sarcoma of the kidney: a report from the National Wilms' Tumor Study Group.
    Green DM; Breslow NE; Beckwith JB; Moksness J; Finklestein JZ; D'Angio GJ
    J Clin Oncol; 1994 Oct; 12(10):2132-7. PubMed ID: 7931484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between dose schedule and charges for treatment on National Wilms' Tumor Study-4. A report from the National Wilms' Tumor Study Group.
    Green DM; Breslow NE; Evans I; Moksness J; Finklestein JZ; Evans AE; D'Angio GJ
    J Natl Cancer Inst Monogr; 1995; (19):21-5. PubMed ID: 7577200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maximal preservation of renal function in patients with bilateral Wilms' tumor: therapeutic strategy of late kidney-sparing surgery and replacement of radiotherapy by high-dose melphalan and stem cell rescue.
    Saarinen-Pihkala UM; Wikström S; Vettenranta K
    Bone Marrow Transplant; 1998 Jul; 22(1):53-9. PubMed ID: 9678796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.